0504U CPT® code: payer coverage and prior authorization

Payer policies and prior authorization for 0504U

Payer coverage policies that name 0504U

0504U appears in 7 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross NC, Blue Shield of California, Cigna, Premera Blue Cross, Regence.

PayerPolicyRole in policyReviewedDocument
AetnaPolymerase Chain Reaction Testing: Selected Indications (0650)not coveredSep 10, 2026payer document
Blue Cross & Blue Shield of MississippiPathogen Panel Testing (L.2.04.456)not coveredpayer document
Blue Cross NCPathogen Panel Testing AHS – G2149listed, no stanceOct 1, 2025payer document
Blue Shield of CaliforniaIdentification of Microorganisms Using Nucleic Acid Probes (2.04.10)listed, no stancepayer document
CignaNucleic Acid Pathogen Testing (0530)not coveredAug 15, 2026payer document
Premera Blue CrossPathogen Panel Testinglisted, no stanceJun 17, 2026payer document
RegenceIdentification of Microorganisms Using Nucleic Acid Probes (Genetic Testing 85)listed, no stanceDec 1, 2025payer document

Medicaid fee-for-service

Prior authorization required or conditional in IN.

  • AZ: $416.78 (lab), effective Oct 1, 2026
  • FL: $225.06 (lab_independent, non-facility), effective Jan 1, 2026
  • KY: $416.78 (lab), effective Jan 1, 2026
  • ND: $0.00 (physician), effective Aug 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.